{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:02:04Z","timestamp":1775602924038,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.canrad.2020.11.002","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T12:31:40Z","timestamp":1610195500000},"page":"316-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6052-8614","authenticated-orcid":false,"given":"F.","family":"Sert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cosgun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Yalman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ozkok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2020.11.002_bib0130","doi-asserted-by":"crossref","first-page":"vi89","DOI":"10.1093\/annonc\/mdt241","article-title":"ESMO Guidelines Working Group. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24 Suppl. 6","author":"Vansteenkiste","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0135","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.7314\/APJCP.2014.15.3.1233","article-title":"A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer","volume":"15","author":"Sun","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.canrad.2020.11.002_bib0140","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/cncr.10687","article-title":"Brain metastases in locally advanced non small cell lung carcinoma after multimodality treatment: risk factors analysis","volume":"95","author":"Ceresoli","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2020.11.002_bib0145","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJM199908123410703","article-title":"Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group","volume":"341","author":"Aup\u00e9rin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2020.11.002_bib0150","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1470-2045(09)70101-9","volume":"10","author":"Le P\u00e9choux","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1200\/JCO.2010.29.1609","article-title":"Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214","volume":"29","author":"Gore","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0160","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/annonc\/mdu567","article-title":"Randomized phase III trial of prophylactic cranial irradiation versus observation in patients with fully resected stage IIIA-N2 nonsmall-cell lung cancer and high risk of cerebral metastases after adjuvant chemotherapy","volume":"26","author":"Li","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0165","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canrad.2020.11.002_bib0170","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor-platelet interaction in solid tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.canrad.2020.11.002_bib0175","doi-asserted-by":"crossref","first-page":"76769","DOI":"10.18632\/oncotarget.12526","article-title":"Prognostic significance of neutrophil lymphocyte ratio\/platelet-lymphocyte ratio in lung cancers: a meta-analysis","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canrad.2020.11.002_bib0180","first-page":"226","article-title":"Lymphopaenia and accidental splenic doses: Do they have any prognostic value for locally advanced gastric cancer patients treated with radiochemotherapy?","volume":"23","author":"Sert","year":"2019","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.canrad.2020.11.002_bib0185","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1148\/rg.2018180060","article-title":"Role of FDG PET\/CT in the eighth edition of TNM staging of non-small cell lung cancer","volume":"38","author":"Kandathil","year":"2018","journal-title":"Radiographics."},{"key":"10.1016\/j.canrad.2020.11.002_bib0190","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2020.11.002_bib0195","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1756-9966-27-80","article-title":"Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients","volume":"27","author":"Yavuz","year":"2008","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.canrad.2020.11.002_bib0200","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0205","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1038\/srep12493","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis","volume":"5","author":"Gu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2020.11.002_bib0210","doi-asserted-by":"crossref","first-page":"23893","DOI":"10.1038\/srep23893","article-title":"Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.canrad.2020.11.002_bib0215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.canrad.2020.11.002_bib0220","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1245\/s10434-016-5206-3","article-title":"A nomogram to predict brain metastases of resected non-small cell lung cancer patients","volume":"23","author":"Zhang","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0225","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2407-9-119","article-title":"Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysis","volume":"9","author":"Arrieta","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2020.11.002_bib0230","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.lungcan.2004.01.025","article-title":"Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma","volume":"45","author":"Bajard","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2020.11.002_bib0235","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1111\/crj.12768","article-title":"Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?","volume":"12","author":"Ozyurek","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.canrad.2020.11.002_bib0240","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/COC.0000000000000070","article-title":"Prognostic significance of standardized uptake value of lymph nodes on survival for stage III non-small cell lung cancer treated with definitive concurrent chemoradiotherapy","volume":"39","author":"Lee","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2020.11.002_bib0245","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.canrad.2020.11.002_bib0250","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/JTO.0000000000000615","article-title":"Targeted therapy for brain metastases in EGFR-mutated and ALK-rearranged non-small cell lung cancer","volume":"10","author":"Baik","year":"2015","journal-title":"J Thorac Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820303607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321820303607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:34:03Z","timestamp":1761136443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321820303607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1278321820303607"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2020.11.002","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2020.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}